These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2309580)

  • 1. Aluminum administration in the rat separately affects the osteoblast and bone mineralization.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1990 Jan; 5(1):59-67. PubMed ID: 2309580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
    Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental aluminum intoxication and parathormone: effects on the mineralization process.
    Ballanti P; Mocetti P; Della Rocca C; Bonucci E; Costantini S; Giordano R; Ioppolo A; Mantovani A
    Miner Electrolyte Metab; 1989; 15(4):233-40. PubMed ID: 2761490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG; Weisbrode SE
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental aluminum-induced bone disease: studies in vivo.
    Goodman WG
    Kidney Int Suppl; 1986 Feb; 18():S32-6. PubMed ID: 3517461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.
    Dunstan CR; Evans RA; Hills E; Wong SY; Alfrey AC
    Calcif Tissue Int; 1984 Mar; 36(2):133-8. PubMed ID: 6430496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone temporal effects on bone formation and resorption.
    Kroll MH
    Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects of aluminum on normal dogs: studies on the isolated perfused bone.
    Galceran T; Finch J; Bergfeld M; Coburn J; Martin K; Teitelbaum S; Slatopolsky E
    Endocrinology; 1987 Jul; 121(1):406-13. PubMed ID: 3036473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat.
    Felsenfeld AJ; Machado L; Rodriguez M
    J Am Soc Nephrol; 1991 Jan; 1(7):970-9. PubMed ID: 1883967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
    J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of osteoblast Phex expression by PTH.
    Alos N; Ecarot B
    Bone; 2005 Oct; 37(4):589-98. PubMed ID: 16084134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
    Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
    Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.